Status:
COMPLETED
Comparison of Different Ratio of Ketofol (6:1 vs. 4:1) for Sedation in Endoscopic Retrograde Cholangiopancreatography (ERCP)
Lead Sponsor:
Indonesia University
Conditions:
Analgesia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Study was aimed to compare the effect of ketofol between 6:1 and 4:1 ratio in patients who underwent ERCP
Detailed Description
Combination of propofol and ketamine (ketofol) has been used as a medication for sedation in various medical procedures such as Endoscopic Retrograde Cholangio-pancreatography (ERCP). The addition of ...
Eligibility Criteria
Inclusion
- Having ERCP procedures using sedatives
- ASA (American Society of Anesthesiologist) physical status Class I to III
- Body mass index (BMI) of 18-30 kg/m2
- Willing to participate in the study
Exclusion
- Patients with a history of allergic reaction to medications used in the study
- Patients with cardiovascular disease, uncontrolled hypertension, respiratory dysfunction
- Patients with unstable hemodynamic
- Patients with psychiatric medications
- Patients with probability of difficult intubation and ventilation Patients with kidney disorder Pregnant women
Key Trial Info
Start Date :
March 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2017
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04029831
Start Date
March 1 2017
End Date
June 1 2017
Last Update
October 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cipto Mangunkusumo General Hospital
Jakarta Pusat, DKI Jakarta, Indonesia, 10430